About Boule
More than 60 years of experience in bringing diagnostics to the point of care
Boule is a global diagnostics company specializing in decentralized blood analysis. With a strong heritage in automated hematology testing, our systems play a vital role in helping to build the healthcare infrastructure for small and medium-sized patient care settings in both the human and veterinary diagnostics markets.
Boule operates via subsidiaries in Sweden, the USA, and Russia. The company products are sold globally primarily through more than 200 distributors in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011.
Innovative Solutions in Diagnostics
Diagnostics products
Boule develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents, controls and calibrators for both human and veterinary diagnostic markets. Consumables are designed and developed in conjunction with the analyzer to provide optimized performance and enhanced serviceability of the complete system.
Boule´s automated hematology analyzers have been used by clinical laboratories in general health screenings across the globe for more than 60 years. Our blood tests help provide one of the first and most important indicators of a disease state.
Customized development and manufacturing
Through our US division Clinical Diagnostic Solutions, we produce high-quality, cost-effective private-label and OEM products for several international medical device companies. We use at a collaborative process to design, develop, and manufacture products to meet our partners’ needs.
We excel in developing products for hematology, flow cytometry, chemistry, and coagulation systems. Our skilled scientific staff is knowledgeable and adaptable, and focus on using high quality materials, workmanship, and documentation best practices.
Global Market
The market for decentralized blood diagnostics accounts for more than one fourth of the global market in human segment and mainly comprises small to medium-sized hospitals, clinics, and hospitals.
Boule products are found in hospitals, reference laboratories and physician office laboratories around the globe. Boule team members are available on each continent and committed to support our customers worldwide. Boule has a distributor-based sales strategy with independent regional distributors who market and sell the company’s products. Together we offer a complete product solution, keeping quality in focus.
Company Strategy
Boule’s strategy focuses on fulfilling its purpose, strengthening the business model, and achieving financial targets. It is built on three strategic pillars designed to drive long-term growth and success.
Strategic Objectives
Boule’s main objectives include reaching 2 BSEK in revenue and maintaining an EBIT margin above 20%. Equally important is creating a workplace where employees thrive and are motivated to contribute to the company’s success.
Strategic Pillars
Boule’s strategy is built on three pillars: accelerating growth, adapting to global markets, and fostering ownership culture. This approach fulfills the company’s purpose, strengthens the business model, and achieves financial targets.
Business model
Boule uses an indirect sales model with distributors for global sales and service. By expanding its installed base of instruments using Boule consumables, the company ensures recurring revenue. A multi-brand strategy and white-label offerings meet diverse market needs.